These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25029663)

  • 21. Spin Trapping Hydroxyl and Aryl Radicals of One-Electron Reduced Anticancer Benzotriazine 1,4-Dioxides.
    Qi W; Yadav P; Hong CR; Stevenson RJ; Hay MP; Anderson RF
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotoxic effects of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) and nitrogen mustard-N-oxide (nitromin) in Walker carcinoma cells under aerobic and hypoxic conditions.
    Cahill A; Jenkins TC; Pickering P; White IN
    Chem Biol Interact; 1995 Mar; 95(1-2):97-107. PubMed ID: 7697757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mass spectrometry study of tirapazamine and its metabolites. insights into the mechanism of metabolic transformations and the characterization of reaction intermediates.
    Zagorevskii D; Song M; Breneman C; Yuan Y; Fuchs T; Gates KS; Greenlief CM
    J Am Soc Mass Spectrom; 2003 Aug; 14(8):881-92. PubMed ID: 12892912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity.
    Guise CP; Abbattista MR; Anderson RF; Li D; Taghipouran R; Tsai A; Lee SJ; Smaill JB; Denny WA; Hay MP; Wilson WR; Hicks KO; Patterson AV
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33105798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugs.
    Wardman P; Priyadarsini KI; Dennis MF; Everett SA; Naylor MA; Patel KB; Stratford IJ; Stratford MR; Tracy M
    Br J Cancer Suppl; 1996 Jul; 27():S70-4. PubMed ID: 8763850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of 3-amino-1,2,4-benzotriazine 1,4-dioxide antitumor agents to oxidizing species following their one-electron reduction.
    Anderson RF; Shinde SS; Hay MP; Gamage SA; Denny WA
    J Am Chem Soc; 2003 Jan; 125(3):748-56. PubMed ID: 12526674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-selective agents derived from 2-quinoxalinecarbonitrile 1,4-di-N-oxides. 2.
    Monge A; Martínez-Crespo FJ; López de Ceráin A; Palop JA; Narro S; Senador V; Marín A; Sainz Y; González M; Hamilton E
    J Med Chem; 1995 Oct; 38(22):4488-94. PubMed ID: 7473576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photochemical and photobiological studies of tirapazamine (SR 4233) and related quinoxaline 1,4-Di-N-oxide analogues.
    Inbaraj JJ; Motten AG; Chignell CF
    Chem Res Toxicol; 2003 Feb; 16(2):164-70. PubMed ID: 12588187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductase.
    Fitzsimmons SA; Lewis AD; Riley RJ; Workman P
    Carcinogenesis; 1994 Aug; 15(8):1503-10. PubMed ID: 8055626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redox-activated, hypoxia-selective DNA cleavage by quinoxaline 1,4-di-N-oxide.
    Ganley B; Chowdhury G; Bhansali J; Daniels JS; Gates KS
    Bioorg Med Chem; 2001 Sep; 9(9):2395-401. PubMed ID: 11553481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine.
    Dorie MJ; Kovacs MS; Gabalski EC; Adam M; Le QT; Bloch DA; Pinto HA; Terris DJ; Brown JM
    Neoplasia; 1999 Nov; 1(5):461-7. PubMed ID: 10933062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrochemical studies and DNA damaging effects of the benzotriazine-N-oxides.
    Tocher JH; Virk NS; Edwards DI
    Biochem Pharmacol; 1990 Feb; 39(4):781-6. PubMed ID: 2137694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzotriazine Di-Oxide Prodrugs for Exploiting Hypoxia and Low Extracellular pH in Tumors.
    Hay MP; Shin HN; Wong WW; Sahimi WW; Vaz ATD; Yadav P; Anderson RF; Hicks KO; Wilson WR
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA-targeted 1,2,4-benzotriazine 1,4-dioxides: potent analogues of the hypoxia-selective cytotoxin tirapazamine.
    Hay MP; Pruijn FB; Gamage SA; Liyanage HD; Kovacs MS; Patterson AV; Wilson WR; Brown JM; Denny WA
    J Med Chem; 2004 Jan; 47(2):475-88. PubMed ID: 14711317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrochemical properties as a function of pH for the benzotriazine di-N-oxides.
    Tocher JH; Virk NS; Edwards DI
    Free Radic Res Commun; 1990; 10(4-5):295-302. PubMed ID: 2289695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrochemical studies of tirapazamine: generation of the one-electron reduction product.
    Tocher JH; Edwards DI
    Free Radic Res; 1994 Oct; 21(5):277-83. PubMed ID: 7842137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.
    Brown JM
    Br J Cancer; 1993 Jun; 67(6):1163-70. PubMed ID: 8512801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The one-electron reduction potential of 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine): a hypoxia-selective bioreductive drug.
    Priyadarsini KI; Tracy M; Wardman P
    Free Radic Res; 1996 Nov; 25(5):393-9. PubMed ID: 8902537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of radicals formed following enzymatic reduction of 3-substituted analogues of the hypoxia-selective cytotoxin 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).
    Shinde SS; Maroz A; Hay MP; Patterson AV; Denny WA; Anderson RF
    J Am Chem Soc; 2010 Mar; 132(8):2591-9. PubMed ID: 20141134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual action of tirapazamine in the induction of DNA strand breaks.
    Jones GD; Weinfeld M
    Cancer Res; 1996 Apr; 56(7):1584-90. PubMed ID: 8603406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.